Europe — EMA
Octreoscan (Indium In-111 Pentetreotide)
Indium In-111 pentapeptide (Indium In-111 pentetreotide), the active ingredient in Octreoscan, is a diagnostic radiopharmaceutical presented as a sterile solution for intravenous use.
Request sourcing
What is Indium In-111 Pentetreotide?
Indium In-111 pentapeptide (Indium In-111 pentetreotide), the active ingredient in Octreoscan, is a diagnostic radiopharmaceutical presented as a sterile solution for intravenous use. It is employed in nuclear medicine imaging to locate neuroendocrine tumors and assess somatostatin receptor expression in adult patients. GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Indium In-111 Pentetreotide used for?
Octreoscan is a radiopharmaceutical used in the evaluation of somatostatin receptor‑positive neuroendocrine tumors. It assists : - Neuroendocrine tumor detection: Helps identify the location and extent of disease in patients with suspected or known neuroendocrine tumors. - Staging of tumor burden and metastasis : Provides visual assessment of tumor distribution through whole‑body scintigraphy or SPECT/CT imaging. - Therapy planning for peptide ‑ - t t t ...
What are the side effects of Indium In-111 Pentetreotide?
Common t ...
What precautions apply to Indium In-111 Pentetreotide?
...
What does Indium In-111 Pentetreotide interact with?
...
